July 7, 2017
Posted August 8, 2017
Wal-Mart Stores Inc. agreed to pay $1.65 million to resolve allegations it violated the False Claims Act by submitting pharmacy claims to California’s Medi‑Cal program not supported by applicable diagnosis and documentation requirements. The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by a Wal-Mart pharmacist. The whistleblower will receive a whistleblower award of roughly $264,000 from the proceeds of the government’s recovery. DOJ (EDCA)
Tagged in: Medicaid, Pharma Fraud, Whistleblower Case, Whistleblower Rewards,